Clinical Trials Logo

Clinical Trial Summary

Ankle sprain is a fairly common sports medicine clinic. In Taiwan at least 150,000 to 200,000 people will suffer from ankle sprains every years. Clinicians have been looking for ways to shorten treatment time and reduce discomfort. Platelet Rich Plasma(PRP) is an endogenous therapeutic technology that involved in regenerative medicine due to its potential to stimulate and accelerate tissue healing. PRP can release lots of growth factors like platelet-derived growth factor (PDGF),transforming Growth Factor Beta(TGF-β), vascular endothelial growth factor(VEGF),Epidermal growth factor(EGF) and insulin-like growth factor (IGF). Its use had been based on the theory that increased autologous platelets, that then yield high concentrations of growth factors and other proteins, will lead to increased healing of tendon and soft tissue on a cellular level. In addition, there is no objective evaluation after treatment, so that patients can not provide effective and accurate quantitative feedback. In this study, the investigators divided patients into three groups, respectively, general rehabilitation therapy, autologous PRP injection therapy, autologous PRP injection combined with general rehabilitation therapy.


Clinical Trial Description

The investigators divided patients into three groups, respectively, general rehabilitation therapy, autologous PRP injection therapy, autologous PRP injection combined with general rehabilitation therapy randomly. The investigators also use the new ankle proprioception evaluation system and evaluation of clinical function after treatment. It is expected to establish another feasible and rapid treatment method for ankle sprain. Combined with high accuracy ankle body defect evaluation method, it is helpful to design proper treatment and rehabilitation strategy in the future so as to improve the rehabilitation of limbs Coordination and control capabilities. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03808454
Study type Interventional
Source National Defense Medical Center, Taiwan
Contact Shang-Lin Chiang, PhD
Phone 8860287923311
Email andyyy520@yahoo.com.tw
Status Recruiting
Phase Phase 4
Start date October 1, 2019
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05596162 - The Effect of Low-Intensity Blood Flow Restriction Therapy on the Management of Acute Ankle Sprains N/A
Terminated NCT04599829 - Assessment of the Safety and Performance of Ankle Ligament Supports in the Context of a Return to Sport After Sprain
Completed NCT03948503 - Mulligan Concept in the Treatment of Ankle Sprains N/A
Completed NCT05217173 - Effectiveness of a Telerehabilitation Program in Ankle Sprain N/A